MyAverix Finance MyAverix Finance

HM

Viromed Medical AG (Q11)

Viromed Medical AG (Q11) is listed on HM. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for Q11

P/E ratio
18.00

Viromed Medical AG (Q11) — FAQ

What is Q11's P/E ratio?

The price-to-earnings (P/E) ratio for Viromed Medical AG (Q11) is 18.00 (data as of 2026-03-22).

Does Viromed Medical AG pay a dividend?

Dividend yield is not available in the current snapshot for Viromed Medical AG (Q11). Check the MyAverix Finance app for the latest dividend data.

What exchange is Q11 listed on?

Q11 is listed on HM.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play